mechlorethamine has been researched along with cyclosporine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Djawari, D; Fluhr, J; Forssman, T; Gloor, M; Rumpelt, HJ | 1 |
| Fox, DA; McCune, WJ | 1 |
| Furst, DE | 1 |
| Raez, LE; Saldana, M; Temple, JD | 1 |
| Boisvieux-Ulrich, E; Brenner, C; Breton, P; Daulon, S; Deniaud, A; Lemaire, C; Marano, F; Sourdeval, M; Taysse, L | 1 |
| Aubert, JD; Duchosal, MA; Laffitte, E; Panizzon, RG; Pascual, M; Venetz, JP | 1 |
3 review(s) available for mechlorethamine and cyclosporine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Immunosuppressive drug therapy of systemic lupus erythematosus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphocyte Subsets; Lymphocytes; Mechlorethamine; Methotrexate | 1994 |
Innovative treatment approaches for rheumatoid arthritis. Cyclosporin, leflunomide and nitrogen mustard.
Topics: Absorption; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Mechlorethamine; Tissue Distribution | 1995 |
5 other study(ies) available for mechlorethamine and cyclosporine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
[Treatment of Langerhans-cell histiocytosis by oral cyclosporin A and topical nitrogen mustard].
Topics: Administration, Oral; Administration, Topical; Cyclosporine; Histiocytosis, Langerhans-Cell; Humans; Male; Mechlorethamine; Middle Aged; Skin Diseases | 1994 |
Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Doxorubicin; Etoposide; Humans; Immunosuppressive Agents; Lung Diseases; Lymphomatoid Granulomatosis; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 1996 |
Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis.
Topics: Animals; Apoptosis; Azoles; Caspases; Cell Adhesion; Cell Membrane Permeability; Cells, Cultured; Cyclosporine; HeLa Cells; Humans; Isoindoles; Mechlorethamine; Melatonin; Mice; Mitochondria; Models, Biological; Multiprotein Complexes; Mustard Gas; Organoselenium Compounds; Proto-Oncogene Proteins c-bcl-2; Respiratory Mucosa; Tumor Suppressor Protein p53 | 2006 |
Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Betamethasone Valerate; Cyclosporine; Humans; Immunocompromised Host; Kidney Diseases; Kidney Transplantation; Lung Transplantation; Male; Mechlorethamine; Mycosis Fungoides; Remission Induction; Skin; Skin Neoplasms | 2008 |